100% Locally Owned, Independent and Free

100% Locally Owned, Independent and Free

University to head trials for 'three-in-one' investigational vaccine

Do you have a news tip? Click here to send to our news team.

Councillor questions residential speed limits

A Sunshine Coast councillor believes lower speed limits may be more appropriate on some residential streets, particularly in areas used regularly by families, pedestrians More

Essential workers priced out of rentals

Essential workers are increasingly being priced out of the Sunshine Coast rental market, with fewer than one per cent of available properties affordable for More

Push to expand cash payment rights

A Sunshine Coast federal MP says Australians should have greater rights to use cash for everyday purchases, arguing the issue is particularly relevant in More

Graffiti fix changes beachfront rock wall

A beachfront rock wall has been painted over after being targeted by graffiti, with council’s response attracting attention on social media. The vandalism covered large More

Modular home builder set for expansion

A modular home builder that has outgrown two Sunshine Coast premises is set to move into a much larger factory capable of almost tripling More

New facilities back women in sport

Women and girls using a Sunshine Coast sports precinct have gained new purpose-built amenities as part of a national push to remove barriers to More

The University of the Sunshine Coast will lead trials for an investigational vaccine that could address three viruses, including COVID-19.UniSC Clinical Trials staff will enrol participants in a Moderna phase 1 trial, of a combination investigational vaccine for COVID-19, influenza and respiratory syncytial virus at its South Bank clinic in Brisbane.This will be the third time UniSC Clinical Trials conducts a trial for Moderna, to evaluate its mRNA technology.

Principal investigator Dr Nischal Sahai will oversee the trial that will assess the safety and immunogenicity of the investigational vaccine.Dr Sahai said the study presented the opportunity to evaluate the potential of investigational combination mRNA vaccines.“The investigational vaccine will be evaluated to see if it can help to reduce the burden of respiratory disease and offer the community the opportunity to be vaccinated for common respiratory viruses with one single dose and a yearly booster thereafter,” he said.“This is an investigational mRNA vaccine which contains acids that are naturally found in our body’s cells. We hope that it will instruct the body to make antibodies when exposed to these three respiratory viruses.”

UniSC will lead the trials. Picture: Shutterstock.

The study requires healthy volunteers between the ages of 50 and 75. Participants will be asked to attend seven clinic visits and eight phone calls over a period of up to 13 months.“The investigational vaccine will be administered by injection into the upper arm muscle, like the annual influenza vaccine,” Dr Sahai said.“It is hoped that by combining the vaccines for these three respiratory viruses there could be increased protection for older people due to the ease at which it could be accessed; much like paediatric vaccines, as well as potentially increasing compliance,” he said.Eligible participants will be paid for their time on the study. Those interested in volunteering can find more information at USC – trials. 

Like stories about Sunshine Coast people doing great things? Help us deliver more by registering for our free daily news feed. All it requires is your name and email. See SUBSCRIBE at the top of this article.

Subscribe to SCN’s free daily news email

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
[scn_go_back_button] Return Home
Share